Exide Industries Ltd (EXIDEIND)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2 FY27 standalone revenue 5,026 Cr +20.3% y-y; H1 revenue 10,331 Cr +18.9% y-y
- EBITDA Q2 606 Cr +53.6% y-y; margin expanded to 12.1% from 9.4% (+270 bps)
- Lithium-ion 6 GWh plant commissioned Sept 23; revenue started from Oct for LFP cells
- Lithium NMC revenue expected from Q4 FY27; OEM validations progressing well
- Lead-acid core business growth strong; calibrated price hikes offset input cost inflation
- Capital allocation: INR400-500 Cr annual capex for core; equity funding continues for lithium
- Expect 80% utilization before phase two lithium capex decision; working capital factored
- Localization of 50-60% raw material for lithium planned in 2-3 years; 20+ local suppliers engaged
- Multiple new OEM launches won for automotive and auxiliary batteries
- Margin corridor for lead-acid business maintained at 12-12.5% for next two quarters
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 EXIDEIND — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add EXIDEIND to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Exide Industries Ltd
Important.
The summary above is generated automatically from Exide Industries Ltd's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.